Description
| Strength | 4.5 MIU |
| Brand Name | Coly Monas |
| Manufacturer | Glenmark Pharmaceuticals Pvt. Ltd |
| Packaging Type | Box |
| Composition | Colistimethate Sodium |
| Packaging Size | 1 Vial |
| Usage/Application | Cystic Fibrosis |
| Dose Form | Injection |
| Shelf Life | 24 Months |
Product’s Details:
- Coly Monas 4.5 MIU Injection contains Colistimethate Sodium, an antibiotic used for treating multidrug-resistant Gram-negative infections, especially in cystic fibrosis and carbapenem-resistant cases.
- Mechanism of Action: It works by disrupting the bacterial cell membrane, making it effective against pathogens like Pseudomonas aeruginosa and Acinetobacter species.
- Indications:
- Cystic fibrosis-related lung infections
- Ventilator-associated pneumonia
- Bloodstream infections caused by resistant Gram-negative bacteria
- Complicated urinary or intra-abdominal infections (as per culture sensitivity)
- Storage Instructions:
- Store below 25°C
- Keep away from direct sunlight and moisture
- Do not freeze
- Reconstitution:
- Use immediately after mixing with sterile water or diluent
- Prepared solution should not be frozen
- Important Notes:
- Reserved for use in last-line treatment protocols
- Should only be administered in hospital settings under professional supervision
- Dosage should follow bacterial culture and sensitivity reports
- Possible Side Effects:
- Kidney toxicity
- Neurotoxicity (e.g., dizziness, numbness)
- Respiratory issues if inhaled
- Allergic reactions (rare)
Reviews
There are no reviews yet.